Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Macrogenics (MGNX) over the last 10 years, with Q3 2025 value amounting to $46.1 million.

  • Macrogenics' Change in Acquisitions & Divestments rose 1248.05% to $46.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.9 million, marking a year-over-year decrease of 6232.81%. This contributed to the annual value of $190.0 million for FY2024, which is 1780.92% up from last year.
  • As of Q3 2025, Macrogenics' Change in Acquisitions & Divestments stood at $46.1 million, which was up 1248.05% from $8.6 million recorded in Q2 2025.
  • Over the past 5 years, Macrogenics' Change in Acquisitions & Divestments peaked at $76.8 million during Q1 2024, and registered a low of $8.6 million during Q2 2025.
  • Over the past 5 years, Macrogenics' median Change in Acquisitions & Divestments value was $45.4 million (recorded in 2022), while the average stood at $43.2 million.
  • As far as peak fluctuations go, Macrogenics' Change in Acquisitions & Divestments surged by 22228.57% in 2024, and later plummeted by 8476.95% in 2025.
  • Macrogenics' Change in Acquisitions & Divestments (Quarter) stood at $54.2 million in 2021, then decreased by 26.73% to $39.8 million in 2022, then surged by 55.75% to $61.9 million in 2023, then plummeted by 74.36% to $15.9 million in 2024, then skyrocketed by 190.5% to $46.1 million in 2025.
  • Its Change in Acquisitions & Divestments was $46.1 million in Q3 2025, compared to $8.6 million in Q2 2025 and $18.3 million in Q1 2025.